OXIS International Inc. filed its 10-K on Jan 08, 2015 for the period ending Dec 31, 2013. In this report its auditor, Seligson & Giannattasio, LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.73 USD | -3.19% |
|
-2.85% | -64.31% |
06-27 | GT Biopharma Says FDA Clears Investigational New Drug Application for Cancer Drug GTB-3650 | MT |
06-27 | GT Biopharma Shares Rise on FDA Clearance for Cancer-Drug Study | DJ |
1st Jan change | Capi. | |
---|---|---|
-64.31% | 6.08M | |
+55.35% | 848B | |
+31.64% | 627B | |
-0.10% | 363B | |
+15.47% | 318B | |
+13.10% | 299B | |
+15.51% | 243B | |
+16.72% | 225B | |
+16.54% | 179B | |
+4.31% | 167B |
- Stock Market
- Equities
- GTBP Stock
- News GT Biopharma, Inc.
- OXIS International Inc. Auditor Raises 'Going Concern' Doubt